Literature DB >> 25501260

Is personalized medicine a panacea for health management? Some thoughts on its desirability.

Fernando Antoñanzas1, Carmelo A Juárez-Castelló, Roberto Rodríguez-Ibeas.   

Abstract

Mesh：

Year:  2015        PMID： 25501260     DOI： 10.1007/s10198-014-0665-6

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  5 in total

1.  Genetic testing in the European Union: does economic evaluation matter?

Authors:  Fernando Antoñanzas; R Rodríguez-Ibeas; M F Hutter; R Lorente; C Juárez; M Pinillos
Journal:  Eur J Health Econ       Date:  2011-05-20

2.  Some economics on personalized and predictive medicine.

Authors:  F Antoñanzas; C A Juárez-Castelló; R Rodríguez-Ibeas
Journal:  Eur J Health Econ       Date:  2014-11-08

Review 3.  Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers.

Authors:  Mark R Trusheim; Ernst R Berndt; Frank L Douglas
Journal:  Nat Rev Drug Discov       Date:  2007-04       Impact factor: 84.694

Review 4.  Is individualized medicine more cost-effective? A systematic review.

Authors:  Maximilian H M Hatz; Katharina Schremser; Wolf H Rogowski
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

5.  Concepts of 'personalization' in personalized medicine: implications for economic evaluation.

Authors:  Wolf Rogowski; Katherine Payne; Petra Schnell-Inderst; Andrea Manca; Ursula Rochau; Beate Jahn; Oguzhan Alagoz; Reiner Leidl; Uwe Siebert
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981
  5 in total
  1 in total

1.  Improving health care systems by building 'more Europe'.

Authors:  F Antoñanzas; C A Juárez-Castelló; R Rodríguez-Ibeas
Journal:  Eur J Health Econ       Date:  2016-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.